Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity

JUNE 15, 2017
Jeffrey D. Dunn, PharmD, MBA, and Douglas S. Burgoyne, PharmD, FAMCP
This activity is supported by an educational grant from Sandoz Inc.

Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity

Faculty
Jeffrey D. Dunn, PharmD, MBA
CCO/SVP
VRx, LLC
VP MagellanRx
Salt Lake City, Utah

Douglas S. Burgoyne, PharmD,
FAMCP
SVP & Market GM MagellanRx
Salt Lake City, Utah


Medical/Editing Support
Jessica Martin
Martin Medical Writing, LLC
Saint Paul, Minnesota


Educational Objectives
After completing this continuing education program, the participant will be able to:
  1. Examine current treatment options in rheumatoid arthritis (RA) and steps to address and/or minimize treatment failure
  2. Identify emerging treatment pathways in RA and associated pathways
  3. Explain the requirements necessary for a biosimilar agent to be approved for use
  4. Illustrate methods to improve care for patients with RA
Target audience: Pharmacists
Type of activity: Application
Release date: June 15, 2017
Expiration date: June 15, 2018
Estimated time to complete activity: 2.0 hours
Fee: Free

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-059-H01-P. The activity is available for CE credit through June 15, 2018.

SHARE THIS SHARE THIS
1
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.